Overview
Dr. Max Kates is the R. Christian B. Evensen Professor and an associate professor of urology and oncology at the Brady Urological Institute at Johns Hopkins. He also directs the Division of Urologic Oncology for the Brady Urological Institute. Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer. He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer. To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009.
Dr. Kates is rated as an Experienced provider by MediFind in Ureteroscopy. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.
His clinical research consists of co-authoring 158 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 North Caroline Street, Floor 4, Floor 4, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Brian Matlaga is a Professor of Urology at Johns Hopkins University School of Medicine and also is the Director of the Stephens Center for Stone Disease as well as the Executive Vice Chair of the James Buchanan Brady Urological Institute. Dr. Matlaga is an internationally recognized expert in the medical and surgical management of patients with urinary stone disease. A frequent contributor to the medical press, with over 180 peer-reviewed publications, Dr. Matlaga’s research has received national and international awards. Dr. Matlaga sits on numerous editorial boards as well as advisory committees and guidelines panels for the American Urological Association, the American Board of Urology, the Endourological Society, and the National Institutes of Health, amongst others. Dr. Matlaga serves as Executive Medical Director of Clinical Affairs for Johns Hopkins Medicine International, the arm of Johns Hopkins Medicine that manages its global presence. In this capacity, he delivers clinical care as well as project leadership across the globe. Dr. Matlaga is rated as an Elite provider by MediFind in Ureteroscopy. His top areas of expertise are Kidney Stones, Bladder Stones, Boils, Ureteroscopy, and Lithotripsy.
Sibley Memorial Hospital
Dr. Patrick Mufarrij is a member of the Johns Hopkins Brady Urologic Institute at Sibley Memorial Hospital and is an expert in endourology, including percutaneous and endoscopic urologic surgery; metabolic stone and causes of the recurrent stone formation; and robotic surgery for the reconstruction of the urinary tract. He also serves as the Division Cheif for Urology at Sibley Memorial Hospital. Dr. Mufarrij earned his undergraduate degree and his medical degree from Georgetown University School of Medicine. He completed residencies in general surgery and urology at New York University School of Medicine, followed by special training in endourology during a fellowship at Wake Forest Baptist Medical Center. During his fellowship, Dr. Mufarrij focused on metabolic kidney stone disease, surgery for complex kidney stones, percutaneous renal surgery and robotic surgery. Dr. Mufarrij is a member of the American Urological Association. Dr. Mufarrij has contributed to numerous publications on the topics of urology. Dr. Mufarrij is rated as a Distinguished provider by MediFind in Ureteroscopy. His top areas of expertise are Kidney Stones, Perirenal Abscess, Carbuncle, Ureteroscopy, and Lithotripsy.
Chesapeake Urology Associates LLC
Julio Davalos is an Urologist in Fulton, Maryland. Dr. Davalos is rated as a Distinguished provider by MediFind in Ureteroscopy. His top areas of expertise are Kidney Stones, Perirenal Abscess, Carbuncle, Ureteroscopy, and Lithotripsy. Dr. Davalos is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Kates isElite. Learn about Bladder Cancer.
- CystectomyDr. Kates isElite. Learn about Cystectomy.
- Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Cancer
- Urothelial CancerDr. Kates isElite. Learn about Urothelial Cancer.
- Distinguished
- NephrectomyDr. Kates isDistinguished. Learn about Nephrectomy.
- Advanced
- EndoscopyDr. Kates isAdvanced. Learn about Endoscopy.
- Erectile Dysfunction (ED)Dr. Kates isAdvanced. Learn about Erectile Dysfunction (ED).
- LymphadenectomyDr. Kates isAdvanced. Learn about Lymphadenectomy.
- MalakoplakiaDr. Kates isAdvanced. Learn about Malakoplakia.
- Prostate CancerDr. Kates isAdvanced. Learn about Prostate Cancer.
- ProstatectomyDr. Kates isAdvanced. Learn about Prostatectomy.
- Experienced
- Adult Soft Tissue SarcomaDr. Kates isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bilateral HydronephrosisDr. Kates isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder ReconstructionDr. Kates isExperienced. Learn about Bladder Reconstruction.
- Chromophobe Renal Cell CarcinomaDr. Kates isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Kates isExperienced. Learn about Clear Cell Sarcoma.
- Enlarged Prostate (BPH)Dr. Kates isExperienced. Learn about Enlarged Prostate (BPH).